Altamira Therapeutics
Basel
About Altamira Therapeutics
Altamira Therapeutics is dedicated to developing novel pharmaceutical therapies to protect hearing, silence tinnitus, and restore balance. Altamira Therapeutics is the leading pioneer in the emerging field of therapies for neurotologic disorders affecting the inner ear.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 11 – 50
- Estimated revenue: Less than $1M
- Total funding: $126.5M
- Funding stage: IPO
- Last round: Post-IPO Equity (Sep 2024)
- Ticker: nasdaq:EARS
- Website: altamiratherapeutics.com
- Phone: +41 61 201 13 50
Industries & Categories
Health Care, Pharmaceutical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/altamira-therapeutics-203973 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.